Investments
3Portfolio Exits
1About AshHill Investments
AshHill Pharmaceutical Investments is a private equity fund focused on investing in life sciences business opportunities. AshHill provides equity capital to both "seed-stage" and established companies with pharmaceutical and medical device platforms that target significant healthcare needs.
Want to inform investors similar to AshHill Investments about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest AshHill Investments News
Jan 7, 2013
Save this article Send to US private equity firm AshHill Investments and Australian VC fund Trans Tasman Commercialisation Fund (TTCF) have invested $4m in London-based biotech company Heart Metabolics. The company will use the funding to advance US clinical development of perhexiline, its lead drug candidate for the treatment of heart failure symptoms in patients with hypertrophic cardiomyopathy (HCM).... To continue reading...
AshHill Investments Investments
3 Investments
AshHill Investments has made 3 investments. Their latest investment was in Armetheon as part of their Series A on August 8, 2014.
AshHill Investments Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/28/2014 | Series A | Armetheon | $7M | Yes | 4 | |
4/17/2014 | Series A - II | |||||
1/3/2013 | Series A |
Date | 8/28/2014 | 4/17/2014 | 1/3/2013 |
|---|---|---|---|
Round | Series A | Series A - II | Series A |
Company | Armetheon | ||
Amount | $7M | ||
New? | Yes | ||
Co-Investors | |||
Sources | 4 |
AshHill Investments Portfolio Exits
1 Portfolio Exit
AshHill Investments has 1 portfolio exit. Their latest portfolio exit was Armetheon on March 30, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/30/2017 | Merger | 1 |
Date | 3/30/2017 |
|---|---|
Exit | Merger |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
AshHill Investments Team
2 Team Members
AshHill Investments has 2 team members, including current Chief Operating Officer, Steven Smith.
Name | Work History | Title | Status |
|---|---|---|---|
Steven Smith | Chief Operating Officer | Current | |
Name | Steven Smith | |
|---|---|---|
Work History | ||
Title | Chief Operating Officer | |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.